A biopharmaceutical company that focuses on Cardiovascular and Metabolic diseases, Oncology, and Respiratory, Inflammation and Autoimmunity, Infection, Neuroscience and Gastrointestinal diseases, ...
Axsome Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel medicines for the management of central nervous system (CNS) disorders.
BioArctic is a Swedish research intensive biopharma company aimed at developing new treatments that address the causes of diseases that affect the Central Nervous System.
Biohaven is a clinical-stage biopharmaceutical company with a portfolio of innovative, late-stage product candidates targeting neurological diseases, including rare disorders.
CEFALY Technology's mission is to solve the global problem of migraine and other headaches. CEFALY Technology is a medical company with a field of activities that covers various therapeutic means ...
Cognitive Genetics LLC (CogGen) is a pre-commercial consumer healthcare company developing the first pre-symptomatic genetic screening panel for predisposition ...
CuraSen Therapeutics is focused on the discovery and development of therapies to treat neurodegenerative diseases, including Parkinson’s Disease, Alzheimer’s Disease and less common ...
Disarm Therapeutics is creating breakthrough disease-modifying therapeutics for patients with neurological diseases by directly treating axonal degeneration, which underlies a broad range of ...
Karuna Pharmaceuticals is a clinical-stage company targeting muscarinic cholinergic receptors for the treatment of psychosis and cognitive impairment across central nervous system (CNS) disorders ...
Laguna Diagnostics, LLC, develops proprietary blood-based, molecular biomarker diagnostic tests for accurate diagnosis of mental disorders and neurodegenerative diseases.
Magnolia Neurosciences aims to discover and develop proprietary, selective, and drug-like small molecule therapeutics for the prevention of neuronal cell death.
Minoryx is a clinical stage biotech company leading the development of new therapies for X-ALD and other Orphan CNS diseases, a group of rare diseases of genetic origin with a high unmet medical ...
Proniras Corporation is a preclinical-stage biotech company focused on development of a new parenteral medical countermeasure (MCM) to treat seizures and brain injury that occurs following ...
